Regulation of glioblastoma stem cells by retinoic acid: Role for Notch pathway inhibition

Oncogene

Volumn 30, Issue 31, 2011, Pages 3454-3467

  Ying, M ^a   Wang, S ^a   Sang, Y ^a   Sun, P ^a   Lal, B ^a   Goodwin, C R ^a   Guerrero Cazares, H ^a   Quinones Hinojosa, A ^a   Laterra, J ^a   Xia, S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer stem cell; differentiation; glioblastoma; Notch; retinoic acid

Indexed keywords

AGAR; CD133 ANTIGEN; CYCLIN D1; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; NOTCH RECEPTOR; PROTEIN P27; RETINOIC ACID; RETINOID; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL INTERACTION; CELL LINEAGE; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; FEMALE; GLIOBLASTOMA; GROWTH DISORDER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MICROARRAY ANALYSIS; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLIN D1; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, NOTCH; RNA-BINDING PROTEINS; SOXB1 TRANSCRIPTION FACTORS; TRETINOIN; TUBULIN;

EID: 79961170670     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.58     Document Type: Article

References (54)

1. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. (2004). Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14: 43-47. (Pubitemid 38167476)
2. An J, Yuan Q, Wang C, Liu L, Tang K, Tian HY et al. 2005. Differential display of proteins involved in the neural differentiation of mouse embryonic carcinoma P19 cells by comparative proteomic analysis. Proteomics, 5, 1656-1668. (Pubitemid 40593272)
3. Bain G, Mansergh FC, Wride MA, Hance JE, Isogawa A, Rancourt SL et al. (2000). ES cell neural differentiation reveals a substantial number of novel ESTs. Funct Integr Genomics 1: 127-139.
4. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. (Pubitemid 44949604)
5. Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W et al. (2007). Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25: 2524-2533. (Pubitemid 47582744)
6. Butowski N, Prados MD, Lamborn KR, Larson DA, Sneed PK, Wara WM et al. (2005). A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma. Int J Radiat Oncol Biol Phys 61: 1454-1459. (Pubitemid 40470428)
7. Chalmers AJ. (2007). Radioresistant glioma stem cells-therapeutic obstacle or promising target? DNA Repair (Amst) 6: 1391-1394. (Pubitemid 47238688)
8. Chearwae W, Bright JJ. (2008). PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. Br J Cancer 99: 2044-2053.
9. Das A, Banik NL, Ray SK. (2008). Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neurooncol 87: 9-22.
10. Dragnev KH, Petty WJ, Dmitrovsky E. (2003). Retinoid targets in cancer therapy and chemoprevention. Cancer Biol Ther 2: S150-S156.
11. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N et al. (2010). NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28: 5-16.
12. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021. (Pubitemid 39331011)
13. Ginestier C, Wicinski J, Cervera N, Monville F, Finetti P, Bertucci F et al. (2009). Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 8: 3297-3302.
14. Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A et al. (2010). Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer Res 70: 2932-2941.
15. Harris TM, Childs G. (2002). Global gene expression patterns during differentiation of F9 embryonal carcinoma cells into parietal endoderm. Funct Integr Genomics 2: 105-119. (Pubitemid 41399309)
16. Jaeckle KA, Hess KR, Yung WK, Greenberg H, Fine H, Schiff D et al. (2003). Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol 21: 2305-2311. (Pubitemid 46621868)
17. Johannessen TC, Bjerkvig R, Tysnes BB. (2008). DNA repair and cancer stem-like cells-potential partners in glioma drug resistance? Cancer Treat Rev 34: 558-567.
18. Jurcic JG, Soignet SL, Maslak AP. (2007). Diagnosis and treatment of acute promyelocytic leukemia. Curr Oncol Rep 9: 337-344. (Pubitemid 47377064)
19. Kageyama R, Ohtsuka T, Shimojo H, Imayoshi I. (2009). Dynamic regulation of Notch signaling in neural progenitor cells. Curr Opin Cell Biol 21: 733-740.
20. Karmakar S, Banik NL, Ray SK. (2008). Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer 112: 596-607. (Pubitemid 351186200)
21. Kumar HR, Zhong X, Sandoval JA, Hickey RJ, Malkas LH. (2008). Applications of emerging molecular technologies in glioblastoma multiforme. Expert Rev Neurother 8: 1497-1506.
22. Lal B, Xia S, Abounader R, Laterra J. (2005). Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clin Cancer Res 11: 4479-4486. (Pubitemid 40825638)
23. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM et al. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403. (Pubitemid 43668737)
24. Mark M, Ghyselinck NB, Chambon P. (2006). Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46: 451-480. (Pubitemid 43271197)
25. Massard C, Deutsch E, Soria JC. (2006). Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol 17: 1620-1624. (Pubitemid 44680880)
26. Mongan NP, Gudas LJ. (2007). Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75: 853-870. (Pubitemid 350086170)
27. Murata-Ohsawa M, Tohda S, Kogoshi H, Sakano S, Nara N. (2005). The Notch ligand, Delta-1, alters retinoic acid (RA)-induced neutrophilic differentiation into monocytic and reduces RA-induced apoptosis in NB4 cells. Leuk Res 29: 197-203. (Pubitemid 39647514)
28. Nasr R, Lallemand-Breitenbach V, Zhu J, Guillemin MC, de The H. (2009). Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. Clin Cancer Res 15: 6321-6326.
29. Niles RM. (2004). Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 555: 81-96. (Pubitemid 39359177)
30. Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
31. Piccirillo SG, Vescovi AL. (2007). Brain tumour stem cells: possibilities of new therapeutic strategies. Expert Opin Biol Ther 7: 1129-1135. (Pubitemid 47307261)
32. Ray J, Gage FH. (2006). Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells. Mol Cell Neurosci 31: 560-573. (Pubitemid 43358027)
33. Reznik TE, Sang Y, Ma Y, Abounader R, Rosen EM, Xia S et al. (2008). Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Mol Cancer Res 6: 139-150. (Pubitemid 351378174)
34. Sangster-Guity N, Yu LM, McCormick P. (2004). Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment. Cancer Biol Ther 3: 1109-1120. (Pubitemid 41350993)
35. See SJ, Levin VA, Yung WK, Hess KR, Groves MD. (2004). 13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme. Neuro Oncol 6: 253-258. (Pubitemid 39136508)
36. Sell S. (2004). Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 51: 1-28. (Pubitemid 38781748)
37. Sell S. (2006). Cancer stem cells and differentiation therapy. Tumour Biol 27: 59-70.
38. Shi Y, Sun G, Zhao C, Stewart R. (2008). Neural stem cell self-renewal. Crit Rev Oncol Hematol 65: 43-53. (Pubitemid 350216477)
39. Shih AH, Holland EC. (2006). Notch signaling enhances nestin expression in gliomas. Neoplasia 8: 1072-1082. (Pubitemid 44936157)
40. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401. (Pubitemid 39551674)
41. Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou MF, Ionescu MC et al. (2009). Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res 69: 458-465.
42. Soprano DR, Teets BW, Soprano KJ. (2007). Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. Vitam Horm 75: 69-95.
43. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466.
44. Sun P, Xia S, Lal B, Eberhart CG, Quinones-Hinojosa A, Maciaczyk J et al. (2009). DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells 27: 1473-1486.
45. Tang XH, Gudas LJ. (2011). Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol 6: 345-364.
46. Towbin H, Staehelin T, Gordon J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354. (Pubitemid 9256559)
47. Vescovi AL, Parati EA, Gritti A, Poulin P, Ferrario M, Wanke E et al. (1999). Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol 156: 71-83. (Pubitemid 29152984)
48. Walsh J, Andrews PW. (2003). Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. APMIS 111: 197-210; discussion 210-191.
49. Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR et al. (2010). Notch promotes radioresistance of glioma stem cells. Stem Cells 28: 17-28.
50. Wei Y, Harris T, Childs G. (2002). Global gene expression patterns during neural differentiation of P19 embryonic carcinoma cells. Differentiation 70: 204-219. (Pubitemid 38230555)
51. Wilson A, Radtke F. (2006). Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 580: 2860-2868. (Pubitemid 43729170)
52. Yu X, Zou J, Ye Z, Hammond H, Chen G, Tokunaga A et al. (2008). Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. Cell Stem Cell 2: 461-471. (Pubitemid 351598078)
53. Yung WK, Kyritsis AP, Gleason MJ, Levin VA. (1996). Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid. Clin Cancer Res 2: 1931-1935. (Pubitemid 27006624)
54. Zhang R, Banik NL, Ray SK. (2007). Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Neurochem Res 32: 2194-2202. (Pubitemid 350059863)